HomeCannabinoidsSōRSE partners with Pascal Biosciences to begin a cannabinoid-based cancer therapy clinical trial

SōRSE partners with Pascal Biosciences to begin a cannabinoid-based cancer therapy clinical trial

Like

0 views

0%

0 0

SōRSE Technology CEO Howard Lee tells Proactive the privately-held Seattle-based company has partnered with Canadian biotech Pascal Biosciences to …

From: Admin

Date: December 26, 2020

Part 1: Making a Terpene and Cannabinoid Calibration Standard

Part 1: Making a Terpene and Cannabinoid Calibration Standard

The Use of Cannabinoids in Neurological Disorders | D. Isaev, Cannafest 2017

The Use of Cannabinoids in Neurological Disorders | D. Isaev, Cannafest 2017

Hourglass™ DISRUPTIVE Patented Time-Release (THC + Cannabinoid) Cream | Grapefruit USA (OTCQB: GPFT)

Hourglass™ DISRUPTIVE Patented Time-Release (THC + Cannabinoid) Cream | Grapefruit USA (OTCQB: GPFT)

CBG🌟Cannabinoids Explained🌟Dr. Pepper Hernandez

CBG🌟Cannabinoids Explained🌟Dr. Pepper Hernandez

Liquid Karma 1000mg THC Syrup w/ Nano-Cannabinoids

Liquid Karma 1000mg THC Syrup w/ Nano-Cannabinoids

Cannabinoid Hyperemesis Syndrome

Cannabinoid Hyperemesis Syndrome

AusCann positioned to be a leading supplier of Australian cannabinoid

AusCann positioned to be a leading supplier of Australian cannabinoid

Leave a Reply Cancel reply